Nigel is a Life Science consultant, motivated by the opportunity to translate basic research into clinical application in a way that benefits patients most effectively. He has a 30-year track record of drug discovery and development in the pharmaceutical, biotechnology and academic sectors; most recently as Director of Translational Science at CellCentric Ltd. During his time with AstraZeneca, Nigel was Executive Project Leader for their Urology Disease Area Franchise, successfully driving forward new company-wide opportunities for patients with prostate and bladder cancers.